Finance

Lists
Why is SABSW down 3,45%?
Dive Deeper
SABSW:NASDAQ
SAB Biotherapeutics, Inc.
0,014 $
-3,45%
(-0,00050) 1D
30 սեպ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SABSW...
Open
0,01 $
High
0,01 $
Low
0,01 $
Mkt. cap
288,43 մլն
Avg. vol.
126,80 հզր
Volume
0,00
52-wk high
0,20 $
52-wk low
0,00 $
Beta
0,86
No. of employees
86
Open
0,01 $
High
0,01 $
Low
0,01 $
Mkt. cap
288,43 մլն
Avg. vol.
126,80 հզր
Volume
0,00
52-wk high
0,20 $
52-wk low
0,00 $
Beta
0,86
No. of employees
86
News stories
From web sources and news partners
About SAB Biotherapeutics, Inc.
CEO-
Employees86
Founded2014
HeadquartersՄայամի Բիչ, Ֆլորիդա, Միացյալ Նահանգներ
Sector-
Websitesab.bio
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
8,97 մլն
9,73 մլն
13,40 մլն
16,17 մլն
Cost of revenue
8,97 մլն
9,73 մլն
13,40 մլն
16,17 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,71 մլն
6,04 մլն
6,60 մլն
7,20 մլն
Operating expense
3,71 մլն
6,04 մլն
6,60 մլն
7,20 մլն
Total operating expenses
12,68 մլն
15,77 մլն
20,00 մլն
23,38 մլն
Operating income
-12,68 մլն
-15,77 մլն
-20,00 մլն
-23,38 մլն
Other non operating income
57,51 մլն
-1,73 մլն
144,40 հզր
-761,00 հզր
EBT including unusual items
45,45 մլն
-16,86 մլն
-18,87 մլն
-22,49 մլն
EBT excluding unusual items
45,45 մլն
-16,86 մլն
-18,87 մլն
-22,49 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
45,45 մլն
-16,86 մլն
-18,87 մլն
-22,49 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-0,41
-
-0,28
Interest and investment income
655,23 հզր
700,74 հզր
1,05 մլն
1,71 մլն
Interest expense
-43,29 հզր
-63,46 հզր
-62,74 հզր
-62,00 հզր
Net interest expenses
611,94 հզր
637,28 հզր
984,45 հզր
1,65 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-11,91 մլն
-15,01 մլն
-19,25 մլն
-22,54 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps